US 12214002
Compositions and methods for treating antibiotic resistance
granted A61KA61K35/742A61P
Quick answer
US patent 12214002 (Compositions and methods for treating antibiotic resistance) held by Seres Therapeutics, Inc. expires Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Seres Therapeutics, Inc.
- Grant date
- Tue Feb 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 30 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K35/742, A61P, A61P1/00, A61P31/04